Showing results (1721-1730 of 2,133) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|April 1, 1981
Bioavailability in man of atenolol and chlorthalidone from a combination formulationJ McAinsh, W Bastain, J Young, et al.Biopharmaceutics & Drug Disposition|April 1, 1981
Bioavailability of propranolol and bendrofluazide formulationsJ McAinsh, B F Holmes, N S Baber, et al.Biopharmaceutics & Drug Disposition|April 1, 1981
The assay and absorption kinetics of oral theophylline-7-acetic acid in the humanS Sved, I J McGilveray, N BeaudoinBiopharmaceutics & Drug Disposition|April 1, 1981
Interrelation between plasma protein binding, rate of injection and the anaesthetic effect of thiopentalH Kurz, B FichtlBiopharmaceutics & Drug Disposition|April 1, 1981
Estimation of the systemic bioavailability of timolol in manR El-RashidyBiopharmaceutics & Drug Disposition|January 1, 1981
The effect of increased caffeine intake on the metabolism and pharmacokinetics of theophylline in manT J Monks, C A Lawrie, J CaldwellBiopharmaceutics & Drug Disposition|January 1, 1981
A propranolol radioimmunoassay and its use in the study of its pharmacokinetics following low dosesG P Mould, J Clough, B A Morris, et al.Biopharmaceutics & Drug Disposition|January 1, 1981
Pharmacokinetics of drugs in blood. I. Unusual distribution of gentamicinM G Lee, M L Chen, S M Huang, et al.Biopharmaceutics & Drug Disposition|June 18, 2015
Physiologically based pharmacokinetic modeling to predict complex drug-drug interactions: a case study of AZD2327 and its metabolite, competitive and time-dependent CYP3A inhibitorsJian Guo, Diansong Zhou, Yan Li, et al.Biopharmaceutics & Drug Disposition|July 16, 2016
TKI combination therapy: strategy to enhance dasatinib uptake by inhibiting Pgp- and BCRP-mediated effluxRonilda D'Cunha, SoHyun Bae, Daryl J Murry, et al.Pageof 214